Loading page…
Healthcare
Pfizer, Inc. holds an AlphaScore of 52/100 within the Healthcare sector based on the October 11, 2026 snapshot. Key metrics highlight a phenomenal gross margin of 74.33% and a conservative debt-to-equity ratio of 0.75. A primary strength is its exceptional gross margin, reflecting the high value of its pharmaceutical portfolio. A notable risk is its negative revenue growth rate of -1.65% combined with a low return on equity (ROE) of 8.99%. Evidence is limited to the supplied dataset.
Written 11/10/2026, 00:23:45 UTC · Snapshot 11/10/2026